HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N(4)-methoxy-5-methylcytosine

Also Known As:

MOMC

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidinones: 71
      - Cytosine: 1880
        N(4)-methoxy-5-methylcytosine: 3

Experts

1.	Chen, B: 1 article (12/2016)
2.	Li, R: 1 article (12/2016)
3.	Wang, H: 1 article (12/2016)
4.	Wang, K: 1 article (12/2016)
5.	Xie, Y: 1 article (12/2016)
6.	Ikeda, Yasuo: 1 article (12/2006)
7.	Kawakami, Yutaka: 1 article (12/2006)
8.	Kodama, Hiroaki: 1 article (12/2006)
9.	Kuwana, Masataka: 1 article (12/2006)
10.	Okazaki, Yuka: 1 article (12/2006)

Related Diseases

1.	Wounds and Injuries (Trauma) 12/20/2016 - "MOMC is an ideal source of cell therapy for tissue regeneration and wound repair."
2.	Neoplasms (Cancer) 10/15/1997 - "In contrast, calcium ionophore (CI) treatment induced rapid and consistent effects in MOMC from both healthy volunteers and cancer patients, including down-regulated CD14 expression, acquisition of dendritic cell morphologic properties, up-regulated MHC and costimulatory molecule expression, and de novo CD83 expression. "
3.	Hypoxia (Hypoxemia) 12/01/2006 - "Functional characteristics, including vWF release upon histamine stimulation and upregulated expression of VEGF and VEGF type 1 receptor in response to hypoxia, were indistinguishable between the MOMC-derived endothelial-like cells and cultured mature endothelial cells. "

Related Drugs and Biologics

1.	Calcium Ionophores
2.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
3.	Histamine (Histamine Dihydrochloride)

Related Therapies and Procedures

1.	Cell- and Tissue-Based Therapy (Cell Therapy)